Fuel for bold innovators

Enabling the future of Healthcare and Life Sciences

Creating the next generation of HealthTech ventures

HERAN is enabling the next generation of healthcare and life sciences technology breakthroughs.

As an active and engaged investor, we invest in great science, bold innovators and companies that aim to have transformative impact.

“Wind extinguishes a candle and energizes a fire”

We invest in teams that are tough, intelligent, perseverant and possess high levels of genuine positivity and an incredible drive to move things forward.

Discover our portfolio

With our expertise, network, guidance, and strong focus we aim to support those pioneers, disruptors and entrepreneurs who want and can improve healthcare in all its facets. We focus on innovation, technologies and science that can generate scalable positive impact and disruption within life sciences and healthcare.

Read more about our strategy

Invested:

2026

Country:

Fluidic Sciences Ltd is a life sciences tools company based in Royston, UK, focused on high‑performance microfluidics platforms for biologics discovery and development. Its technologies are used across antibody discovery, cell line development, cell engineering and advanced biophysical analysis.

Invested:

2026

Country:

Pharmacelera is a Barcelona based company developing in-silico drug discovery technologies that allow biotech and pharmaceutical companies to create new compounds in an efficient manner. Its technology enables the design of novel, unique, and diverse molecules from trillions of potential candidates up to 75,000 times faster than traditional approaches. The company serves Pharma and biotech customers across Europe and the United States.

Invested:

2025

Country:

Gynaia is a women’s health diagnostics company that empowers gynecological professionals with continuous learning, certification, and clinical-grade AI tools to improve care in gynecologic oncology, early pregnancy, obstetrics, fertility, and beyond.
By combining explainable AI, regulatory-grade software, and a global expert network, Gynaia enables faster triage, earlier diagnoses, and fewer unnecessary procedures.

Who are we?

Heran Partners is a specialist venture capital investor committed to creating transformative impact within the life sciences and healthcare industry. We are a Belgium-based investment fund driven by a dedicated team with strong scientific and entrepreneurial backgrounds. We provide venture & growth capital accompanied by a strong network, expertise and mentorship to start-ups and scale-ups with a solid technology platform and strong market potential.

Meet the team